Impact of contact force sensing technology on outcome of catheter ablation of idiopathic pre-mature ventricular contractions originating from the outflow tracts.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
06 04 2021
Historique:
received: 19 06 2020
accepted: 21 09 2020
pubmed: 19 11 2020
medline: 10 8 2021
entrez: 18 11 2020
Statut: ppublish

Résumé

Catheter ablation of frequent idiopathic pre-mature ventricular contractions (PVC) is increasingly performed. While potential benefits of contact force (CF)-sensing technology for atrial fibrillation ablation have been assessed in several studies, the impact of CF-sensing on ventricular arrhythmia ablation remains unknown. This study aimed to compare outcomes of idiopathic outflow tract PVC ablation when using standard ablation catheters as opposed to CF-sensing catheters. In a retrospective multi-centre study, unselected patients undergoing catheter ablation of idiopathic outflow tract PVCs between 2013 and 2016 were enrolled. All procedures were performed using irrigated-tip ablation catheters and a 3D electro-anatomical mapping system. Sustained ablation success was defined as a  ≥80% reduction of pre-procedural PVC burden determined by 24 h Holter ECG during follow-up. Overall, 218 patients were enrolled (median age 52 years, 51% males). Baseline and procedural data were similar in the standard ablation (24%) and the CF-sensing group (76%). Overall, the median PVC burden decreased from 21% (IQR 10-30%) before ablation to 0.2% (IQR 0-3.0%) after a median follow-up of 2.3 months (IQR 1.4-3.9 months). The rates of both acute (91% vs. 91%, P = 0.94) and sustained success (79% vs. 74%, P = 0.44) were similar in the standard ablation and the CF-sensing groups. No differences were observed in subgroups according to arrhythmia origin from the RVOT (65%) or LVOT (35%). Complications were rare (1.8%) and evenly distributed between the two groups. The use of CF-sensing technology is not associated with increased success rate nor decreased complication rate in idiopathic outflow tract PVC ablation.

Identifiants

pubmed: 33207371
pii: 5989813
doi: 10.1093/europace/euaa315
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

603-609

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Tobias Reichlin (T)

Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.
Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Samuel H Baldinger (SH)

Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.

Etienne Pruvot (E)

Department of Cardiology, University Hospital Lausanne, Lausanne, Switzerland.

Laurence Bisch (L)

Department of Cardiology, University Hospital Lausanne, Lausanne, Switzerland.

Peter Ammann (P)

Department of Cardiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

David Altmann (D)

Department of Cardiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Benjamin Berte (B)

Department of Cardiology, Luzerner Kantonsspital, Lucerne, Switzerland.

Richard Kobza (R)

Department of Cardiology, Luzerner Kantonsspital, Lucerne, Switzerland.

Laurent Haegeli (L)

Department of Cardiology, University Heart Center Zurich, Zurich, Switzerland.
Department of Cardiology, Medical University Department, Kantonsspital Aarau, Aarau, Switzerland.

Christian Schlatzer (C)

Department of Cardiology, University Heart Center Zurich, Zurich, Switzerland.

Andreas Mueller (A)

Department of Cardiology, Triemli Hospital, Zurich, Switzerland.

Mehdi Namdar (M)

Department of Cardiology, University Hospital Geneva, Geneva, Switzerland.

Dipen Shah (D)

Department of Cardiology, University Hospital Geneva, Geneva, Switzerland.

Haran Burri (H)

Department of Cardiology, University Hospital Geneva, Geneva, Switzerland.

Giulio Conte (G)

Department of Cardiology, Fundazione Cardiocentro Ticino, Lugano, Switzerland.

Angelo Auricchio (A)

Department of Cardiology, Fundazione Cardiocentro Ticino, Lugano, Switzerland.

Sven Knecht (S)

Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Stefan Osswald (S)

Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Babken Asatryan (B)

Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.

Jens Seiler (J)

Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.

Laurent Roten (L)

Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.

Michael Kühne (M)

Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Christian Sticherling (C)

Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH